Wuxi Biologics Stock Today
| WXIBF Stock | USD 1.86 0.00 0.00% |
Performance8 of 100
| Odds Of DistressLess than 9
|
WuXi Biologics is trading at 1.86 as of the 30th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.86. WuXi Biologics has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for WuXi Biologics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
WuXi Biologics Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the Peoples Republic of China, North America, Europe, and internationally. The company was incorporated in 2014 and is headquartered in Wuxi, China. The company has 4.22 B outstanding shares. More on WuXi Biologics
Moving against WuXi Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
WuXi Pink Sheet Highlights
| CEO, Executive Director | Zhisheng Chen |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
WuXi Biologics [WXIBF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 34.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate WuXi Biologics's market, we take the total number of its shares issued and multiply it by WuXi Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. WuXi Biologics classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 4.22 B outstanding shares.
WuXi Biologics has accumulated about 9.86 B in cash with 3.43 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check WuXi Biologics Probability Of Bankruptcy
Ownership AllocationWuXi Biologics retains a total of 4.22 Billion outstanding shares. 30% of WuXi Biologics outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check WuXi Ownership Details
WuXi Biologics Risk Profiles
| Mean Deviation | 2.13 | |||
| Standard Deviation | 6.07 | |||
| Variance | 36.9 | |||
| Risk Adjusted Performance | 0.086 |
WuXi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in WuXi Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
WuXi Biologics Corporate Management
Other Information on Investing in WuXi Pink Sheet
WuXi Biologics financial ratios help investors to determine whether WuXi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WuXi with respect to the benefits of owning WuXi Biologics security.